K43TW011167
Project Grant
Overview
Grant Description
The role of HBF decline and its determinants on sickle cell disease expression in the first three years of life.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Pittsburgh,
Pennsylvania
15261
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 501% from $88,940 to $534,119.
Muhimbili University Of Health And Allied Sciences was awarded
HBF Decline & Determinants on Sickle Cell Expression in Early Life
Project Grant K43TW011167
worth $534,119
from Fogarty International Center in August 2019 with work to be completed primarily in Pittsburgh Pennsylvania United States.
The grant
has a duration of 4 years 8 months and
was awarded through assistance program 93.989 International Research and Research Training.
The Project Grant was awarded through grant opportunity Emerging Global Leader Award (K43).
Status
(Complete)
Last Modified 9/5/24
Period of Performance
8/1/19
Start Date
4/30/24
End Date
Funding Split
$534.1K
Federal Obligation
$0.0
Non-Federal Obligation
$534.1K
Total Obligated
Activity Timeline
Transaction History
Modifications to K43TW011167
Additional Detail
Award ID FAIN
K43TW011167
SAI Number
K43TW011167-3915517215
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Non-Domestic (Non-U.S.) Entity
Awarding Office
75NF00 NIH FOGARTY INTERNATIONAL CENTER
Funding Office
75NF00 NIH FOGARTY INTERNATIONAL CENTER
Awardee UEI
U61RWTFLV559
Awardee CAGE
SDD70
Performance District
PA-12
Senators
Robert Casey
John Fetterman
John Fetterman
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| John E. Fogarty International Center, National Institutes of Health, Health and Human Services (075-0819) | Health research and training | Grants, subsidies, and contributions (41.0) | $537,359 | 100% |
Modified: 9/5/24